Status:
COMPLETED
Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque
Lead Sponsor:
Astellas Pharma Inc
Conditions:
Hypercholesteremia
Coronary Artery Disease
Eligibility:
All Genders
20-74 years
Phase:
PHASE4
Brief Summary
To evaluate the efficacy of intensive lipid-lowering therapy with Lipitor on the changes of characteristics of yellow coronary plaque in subjects with hypercholesteremia accompanying coronary artery d...
Eligibility Criteria
Inclusion
- Patients with hypercholesteremia
- The indication of coronary angiography, coronary angioscopy and intravascular ultrasound are expected
Exclusion
- Patients who has current administration of Lipitor or history of discontinued administration of Lipitor
- Acute cardiac infarction
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00408382
Last Update
November 17 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Osaka, Japan
2
Tokyo, Japan